COLOPL Group Blockchain Game Company Brilliantcrypto, Confirms Partnership with Coincheck Ahead of IEO
Brilliantcrypto, Inc. (HQ: Minato City Tokyo, CEO: Naruatsu Baba, henceforth “Brilliantcrypto”) has partnered with the crypto asset trading service provider Coincheck, Inc. (HQ: Shibuya City Tokyo, CEO: Satoshi Hasuo, henceforth “Coincheck”) ahead of an IEO※1 (Initial Exchange Offering, henceforth “IEO”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230719966068/en/
Brilliantcrypto
Brilliantcrypto was established in November 2022 as a wholly owned subsidiary of COLOPL, Inc. (CEO: Takashi Miyamoto, HQ: Minato City Tokyo), to carry out GameFi※2 projects using blockchain technology.
With this partnership, and through the interconnected business of Brilliantcrypto’s currently in-development blockchain game and Coincheck’s crypto asset trading service, the two companies will work together in creating a new game experience and GameFi market on the global stage.
The large-scale Japanese blockchain game project currently in development shall introduce “Proof of Gaming,” a new concept that works for the benefit of others (through guaranteeing value), inspired by the “Proof of Work”※3 mechanism of Bitcoin. Through doing this, it aims to make sustainable play-to-earn※4 a reality.
By utilizing the crypto asset exchange user base and sales network of Coincheck, which is the largest scale exchange and has the best track record with IEOs among domestic crypto exchanges, Brilliantcrypto plans to acquire trust, and aims to achieve a highly enthusiastic user base from the launch period of the game.
Brilliantcrypto will be holding a presentation on July 25th 14:00 JST at the “WebX 2023” event, which will be held at the Tokyo International Forum on July 25th and July 26th. WebX 2023 is a large-scale global conference where the main players in Web3 from countries around the world will gather. On the day, the founder and current chairman of COLOPL, Inc., Mr. Naruatsu Baba will be presenting.
You can view the online livestream by following the link below.
https://www.youtube.com/watch?v=0iEFIMpkf9Q
Comment from Isaka Tomoyuki (Coincheck, Vice-President, Executive Committee Member & Crypto Asset Operations Department Manager)
The GameFi market is still developing, and there is a demand for this new type of game experience that combines finance and entertainment using blockchain technology. Currently, there are many debates taking place about GameFi around the world. But I believe that between theorizing about it, and actually shaping it into something that you can implement into the design of a game that is actually playable, there exists an extraordinarily large gap.
The COLOPL group and its Chief Creator Naruatsu Baba are a rare force in the industry that bridges that gap by delivering original game design aligned with new eras in the gaming industry to their users. I am therefore very pleased to be working on an IEO with the creative team from Brilliantcrypto which is spearheaded by Mr. Baba.
As a leading company for IEOs and crypto asset exchange in Japan, we want to put our full support behind companies that aim to develop the Web3/Crypto industry, or creators that are giving this new type of game design a challenge.
Comment from Naruatsu Baba (CEO of Brilliantcrypto)
Brilliantcrypto was established to take on the challenges of blockchain gaming, and create games that truly shine and stand out. We feel empowered and elated that Coincheck felt a deep connection with our vision “to harness the power of games and blockchain technology to create new value,” and thus decided to become our IEO partner.
Through the partnership of our company, which has spent many years using technology and individualistic ideas to carry out business in the mobile gaming industry, with Coincheck, the largest cryptocurrency exchange in the domestic market, we aim to make a huge impact in not only the Japanese Web3 industry, or even just in the gaming industry, but in all areas of the world.
On July 25th at the WebX 2023 event, which is to be held at the Tokyo International Forum, I plan to deliver a presentation personally and reveal the project to the world. Please look forward to our project, which will bring a never-seen-before, new type of value out into the world.
※1: IEO describes the public offering, sale, and distribution of crypto assets (tokens) that takes place after a project audit/inspection with crypto assets exchange as the medium, following the rules of the Japanese domestic regulation. Until now there have been 4 examples of IEOs performed domestically. Coincheck has carried out two of these including the very first domestic IEO, through the Coincheck IEO platform.
※2: GameFi is a word that combines Game and Finance to describe games that include mechanisms through which one can earn through gameplay, which is made possible by integrating blockchain technology with crypto assets.
※3: Proof of Work (PoW) is one of the consensus algorithms that allows crypto assets to be mined. It allows the transaction and sending of crypto assets, starting with Bitcoin, to be correctly recorded on the blockchain through calculations and verification work. This calculation and verification work is called “mining,” and those who carry it out are called “miners.” PoW is the process in which agreement is reached that the data is correct between the miners through mining.
※4: Play-to-earn is a concept which describes games which make it possible to earn through gameplay, made possible by integrating blockchain technology with crypto assets.
■About Coincheck
Coincheck, Inc. operates a crypto assets exchange platform which for 4 years in a row, has been No.1 in application downloads in that category*. Coincheck’s mission is “Making Exchange of New Values Easier.” Using a foundation of the latest technology and the highest level of security, it aims to create the best service whereby users can feel closer to the “exchange of new values,” which is brought about through crypto assets and blockchain technology.
*Scope: Domestic Crypto Assets Exchange Platforms. Period: 2019/01〜2022/12 Data from App Tweak
Company Name: Coincheck, Inc.
Headquarters: Tokyo, Shibuya City, Maruyamacho, 3-6, 12F E. Space Tower
Founded: 2012/08/28
Executive Director: Satoshi Hasuo
Crypto Asset Exchange Business Registration: Kanto Local Finance Bureau No. 00014
Coincheck, Inc. Corporate Site: https://corporate.coincheck.com/
■About Brilliantcrypto, Inc.
Brilliantcrypto was established in November 2022 as a wholly owned subsidiary by COLOPL, Inc., to carry out GameFi projects using blockchain technology. It was established to take on the challenges of blockchain gaming, and create games that truly shine and stand out. Using both blockchain technology, and the bountiful knowledge gained through the COLOPL group’s many years creating video games, we will create new value on a global scale.
Company Name: Brilliantcrypto, Inc.
Headquarters: Tokyo, Minato City, Akasaka 9-7-2, 5F & 6F Midtown East
Founded: 2022/11/09
Executive Director: Naruatsu Baba
Brilliantcrypto, Inc. Corporate Site: https://brypto.net
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230719966068/en/
Contact information
<Point of Contact regardings inquiries from the media on this release>
Brilliantcrypto PR Representative: Hugo Church, Naoki Nose, Yasuhiro Noguchi
Mail: press.contact@brilliantcrypto.net
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 09:00:00 EET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.” Merz Therapeutics will share new findings reflecting its continued dedication to advancing neurotoxin science. These include: Lower Limb Spasticity Incobotulinumto
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 08:05:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additionally, Galderma and L’Oréal aim at exploring additional scientific research projects of mutual interest. This ongoing collaboration brings together Galderma’s scientific leadership i
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release
Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
